Axcelis Technologies, Inc.
ACLS Mid CapTechnology · Semiconductor Equipment & Materials
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Axcelis Technologies, Inc. en bref
Axcelis Technologies, Inc. (ACLS) is currently trading at 163,65 € with a market capitalization of 5,0 Md €. The trailing P/E ratio stands at 58.24x, with a forward P/E of 40.45x. The 52-week range spans from 56,39 € to 169,11 €; the current price is 3.2% below the yearly high. Year-over-year revenue growth stands at +3.3%. The net profit margin stands at 11.93%.
💰 Dividende
Axcelis Technologies, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
3 analystes évaluent Axcelis Technologies, Inc. (ACLS) au consensus : Acheter. L'objectif de cours moyen est de 140,50 €, soit un potentiel de -14.15% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 113,45 € à 157,08 €.
Axcelis Technologies, Inc. : la thèse d'investissement en détail
Axcelis Technologies, Inc. (ACLS) operates in the Technology — specifically Semiconductor Equipment & Materials — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario baissier
Revenue growth has slowed to just 3.3%, which is below nominal GDP — the business is no longer outgrowing the broader economy. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion. With a beta near 1.92, the share price moves sharply more than the broader market — drawdowns in market corrections can be unusually severe and require strong nerves.
Valorisation en contexte
The PEG ratio at 1.45 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 47.52x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.
À surveiller
- The forward P/E of 40.45x is meaningfully below the trailing 58.24x — analysts expect earnings to step up; the next earnings release is the test.
- The share is trading at 95.2% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.
Thèse d'investissement : forces et faiblesses
- Consensus des analystes : Buy
- Bilan solide avec faible endettement (D/E 6.75)
- Free cash flow positif
- –Multiple de valorisation élevé (P/E 58.24x)
- –Actuellement jugée surévaluée
- –Positions vendeuses élevées (11.97%)
- –Cours proche du plus haut 52 semaines — faible marge de hausse
Aperçu technique
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profil de risque
The data points to above-average price swings, elevated short interest (11.97%).
Trading Data
Related Stocks in the Same Sector
More Technologie stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Axcelis Technologies, Inc.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
